佰金生命科学(01466)拟折让约14.29%发行4000万股认购股份 净筹约1910万港元

智通财经
Sep 29

智通财经APP讯,佰金生命科学(01466)公布,于2025年9月29日( 联交所交易时段后 ),公司( 作为发行人 )与认购人各自订立认购协议,以按认购价每股股份0.48港元认购合共4000万股认购股份。认购价较股份于2025年9月29日( 即认购协议日期 )在联交所所报收市价每股0.56港元折让约14.29 %。

认购事项净筹约1910万港元,拟用作集团的一般营运资金。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10